Age of VC
20 years
Team size
40 employees + 6 visiting analysts
Locations
Zug, Berlin, London, San Francisco (outpost)
Fund volume
Over CHF 1bn AuM
Focus stage / Vertical geographic
redalpine operates as a pan-European multi‑stage investor, able to invest from seed / early rounds through growth / pre‑IPO stages via its early-stage funds and multi-stage Summit Fund. redalpine’s investment strategy targets companies at the connection of software and science, with sector focuses including AI, deeptech, fintech, healthtech, biotech, energy, and more.
Top 3 investments
Investment director
Dr. Michael Sidler
Dr. Michael Sidler is a Founding Partner of redalpine, the European venture capital fund specializing in software and science investments. He earned his Ph.D. in molecular biology from the University of Zurich and began his career as a consultant at the Boston Consulting Group. During the dotcom bubble, Michael ventured into angel investing, where his early losses only deepened his passion for startups. In 2003, he joined Prionics, a pioneering Swiss startup, before transitioning to venture capital, co-founding redalpine in 2006. Michael currently serves on numerous startup boards, including at Aktiia, Lunaphore, ExpressionEdits and Apoha, where he supports founders in turning their visions into a reality.
-
Read more: Redalpine: At Face ValueLab Rat turned Gardener Michael Sidler, Founder and Partner at redalpine, has spent a fair share of his career in a lab. As a trained…
-
Read more: Redalpine: Backed to the FutureComing to Play Michael Sidler likes to describe redalpine as a “one-stop shop” for founders. “We don’t only provide money,” he says. “We provide infrastructure,…
-
Read more: Redalpine: A Matter of ScaleBigger Cakes and Smaller Slices With a name like redalpine, a powerful symbol of a rising sun amidst the impressive peaks of the Swiss alps,…
